{
    "SPADE_N_13495": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13495",
            "Peptide Name": "Amolopin (UCLL1c; natural AMPs; frog, amphibians, animals; XXA)",
            "Source": "Amolops loloensis, China, Asia",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "FLPIVGKSLSGLSGKL",
            "Sequence Length": 16,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "anti-diabetes"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 1615.95,
            "PI": 10.0,
            "Hydrophobicity": 0.86,
            "Half Life": "Not found",
            "Literature": [
                {
                    "Author": "Mo GX, Bai XW, Li ZJ, Yan XW, He XQ, Rong MQ. 2014",
                    "Reference": "Nat Prod Bioprospect. 2014 Oct;4(5):309-13. doi: 10.1007/s13659-014-0037-z.PubMed.",
                    "Title": "A Novel Insulinotropic Peptide from the Skin Secretions of Amolops loloensis Frog."
                }
            ],
            "Frequent Amino Acids": "LGS",
            "Absent Amino Acids": "ACDEHMNOQRTUWY",
            "Basic Residues": 2,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 8,
            "Polar Residues": 6,
            "Positive Residues": 2,
            "Negative Residues": 0,
            "Net Charge": 2,
            "Function": "Amolopin can stimulate insulin release in INS-1 cells in a dose-dependent manner, thereby of interest for type 2 diabetes (T2D). The original incomplete 43 kDa bacteriocin was replaced.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_21403",
                    "Similarity": 1.0,
                    "Sequence": "GLSSLGKLL"
                },
                {
                    "SPADE_ID": "SPADE_UN_00552",
                    "Similarity": 1.0,
                    "Sequence": "SGKLCCRRKK"
                },
                {
                    "SPADE_ID": "SPADE_UN_00553",
                    "Similarity": 1.0,
                    "Sequence": "SGKLYYRRKK"
                }
            ]
        }
    }
}